KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Capital Leases (2018 - 2025)

Labcorp Holdings' Capital Leases history spans 8 years, with the latest figure at $64.3 million for Q3 2025.

  • For Q3 2025, Capital Leases fell 14.49% year-over-year to $64.3 million; the TTM value through Sep 2025 reached $64.3 million, down 14.49%, while the annual FY2024 figure was $74.3 million, 5.47% down from the prior year.
  • Capital Leases for Q3 2025 was $64.3 million at Labcorp Holdings, down from $65.6 million in the prior quarter.
  • Across five years, Capital Leases topped out at $87.2 million in Q2 2021 and bottomed at $64.3 million in Q3 2025.
  • The 5-year median for Capital Leases is $81.7 million (2023), against an average of $78.8 million.
  • The largest annual shift saw Capital Leases increased 0.6% in 2022 before it dropped 14.69% in 2025.
  • A 5-year view of Capital Leases shows it stood at $84.6 million in 2021, then dropped by 1.18% to $83.6 million in 2022, then decreased by 5.98% to $78.6 million in 2023, then decreased by 5.47% to $74.3 million in 2024, then dropped by 13.46% to $64.3 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Capital Leases are $64.3 million (Q3 2025), $65.6 million (Q2 2025), and $66.5 million (Q1 2025).